MRK vs COR
By Alex · Tickerpine
Merck & Co., Inc. vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | COR |
|---|---|---|
| Price | $147.76 | $359.03 |
| Market cap | $364.26B | $68.51B |
| P/E ratio | 149.3 | 20.0 |
| ROE | 5.06% | 129.01% |
| Profit margin | 3.64% | 1.03% |
| Revenue growth | 4.70% | 5.50% |
| Dividend yield | 2.30% | 0.74% |
| Beta | 0.12 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs COR in plain English
- MRK is the bigger company — about 5.3× the market cap of COR.
- COR is cheaper on earnings (P/E 20.0 vs 149.3).
- COR earns a higher return on equity (129% vs 5%).
- COR is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.74%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.